IL196132A - Use of the microalgae Ephenizomonone Plus Aqua Microfiber for the preparation of a medicine for the prevention, control or treatment of disease, condition, dysfunction or neurological disorders - Google Patents

Use of the microalgae Ephenizomonone Plus Aqua Microfiber for the preparation of a medicine for the prevention, control or treatment of disease, condition, dysfunction or neurological disorders

Info

Publication number
IL196132A
IL196132A IL196132A IL19613208A IL196132A IL 196132 A IL196132 A IL 196132A IL 196132 A IL196132 A IL 196132A IL 19613208 A IL19613208 A IL 19613208A IL 196132 A IL196132 A IL 196132A
Authority
IL
Israel
Prior art keywords
afa
extract
phytochrome
use according
phycocyanin
Prior art date
Application number
IL196132A
Other languages
English (en)
Hebrew (he)
Other versions
IL196132A0 (en
Original Assignee
Nutratec S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutratec S R L filed Critical Nutratec S R L
Publication of IL196132A0 publication Critical patent/IL196132A0/en
Publication of IL196132A publication Critical patent/IL196132A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL196132A 2006-06-27 2008-12-23 Use of the microalgae Ephenizomonone Plus Aqua Microfiber for the preparation of a medicine for the prevention, control or treatment of disease, condition, dysfunction or neurological disorders IL196132A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81659306P 2006-06-27 2006-06-27
PCT/EP2007/005622 WO2008000430A2 (en) 2006-06-27 2007-06-26 Alphanizomenon flos aquae preparation, extracts and purified components thereof for the treatment of neurological, neurodegenerative and mood disorders

Publications (2)

Publication Number Publication Date
IL196132A0 IL196132A0 (en) 2009-09-22
IL196132A true IL196132A (en) 2014-06-30

Family

ID=38529410

Family Applications (1)

Application Number Title Priority Date Filing Date
IL196132A IL196132A (en) 2006-06-27 2008-12-23 Use of the microalgae Ephenizomonone Plus Aqua Microfiber for the preparation of a medicine for the prevention, control or treatment of disease, condition, dysfunction or neurological disorders

Country Status (20)

Country Link
US (1) US9522167B2 (ja)
EP (1) EP2046354B1 (ja)
JP (1) JP5259585B2 (ja)
KR (1) KR20090035490A (ja)
CN (1) CN101478980B (ja)
AT (1) ATE519491T1 (ja)
AU (1) AU2007264042B2 (ja)
CA (1) CA2656154C (ja)
DK (1) DK2046354T3 (ja)
ES (1) ES2370533T3 (ja)
HR (1) HRP20110771T1 (ja)
IL (1) IL196132A (ja)
MY (1) MY146594A (ja)
PL (1) PL2046354T3 (ja)
PT (1) PT2046354E (ja)
RS (1) RS52072B (ja)
RU (1) RU2441663C2 (ja)
SI (1) SI2046354T1 (ja)
WO (1) WO2008000430A2 (ja)
ZA (1) ZA200900747B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20070391A1 (it) * 2007-06-05 2008-12-06 Medestea Res & Production S P Composizione di integratore alimentare,farmaco o dispositivo medicale e suo impiego per sopprimere l'appetito, migliorare tono ed umore, con attivita antidepressiva naturale e con effetto antiastenico
KR100969325B1 (ko) * 2010-02-08 2010-07-09 인천대학교 산학협력단 홍조류로부터 비독성 자외선 차단용 추출물을 제조하는 방법 및 이를 이용한 비독성 자외선 차단제
EP2568992A4 (en) * 2010-05-11 2013-11-06 Benzion Geshuri PHARMACEUTICAL COMPOSITION COMPRISING AN ALGUE APPROPRIATE FOR INCREASING THE EFFICACY OF AN ENZYMATIC INHIBITOR
US8906361B2 (en) * 2011-03-28 2014-12-09 John V. Cappello Anti-aging formulations
CU23963B1 (es) * 2011-07-01 2013-12-11 Ct De Ingeniería Genética Y Biotecnología Composiciones farmacéuticas a partir de derivados de la c-ficocianina y combinaciones con interferones del tipo i para el tratamiento de enfermedades cerebrales isquémicas y neurodegenerativas
US20180250351A1 (en) * 2015-09-03 2018-09-06 Stefano Scoglio Cyanobacterial microalgae phycocyanin and phycocyanobilin to beneficially inhibit the activity of the UDP-GDH enzyme while significantly increasing the absorption and circulation of curcumin
JP6719267B2 (ja) * 2016-04-27 2020-07-08 長瀬産業株式会社 安定化されたマイコスポリン様アミノ酸を含有する溶液、およびその製造方法
JP7257479B2 (ja) * 2016-04-27 2023-04-13 長瀬産業株式会社 安定化されたマイコスポリン様アミノ酸を含有する溶液、およびその製造方法
JP6964707B2 (ja) * 2016-04-27 2021-11-10 長瀬産業株式会社 安定化されたマイコスポリン様アミノ酸を含有する溶液、およびその製造方法
AU2017259736A1 (en) * 2016-05-02 2018-12-20 Stefano Scoglio The use of phycocyanins, purified or as present in cyanobacterial microalgae or extracts thereof, as prebiotics, to enhance the viability, gastrointestinal survival, pathogen-fighting ability, and the overall health-enhancing properties of probiotic cultures and products.
EP3678743A1 (en) 2017-09-06 2020-07-15 Stefano Scoglio The transdermal use of cyanobacterial algae, and/or extracts thereof, via low or high intensity transporation devices for beauty and health enhancing purposes
KR102003911B1 (ko) * 2018-02-23 2019-07-25 씨제이제일제당 주식회사 마이코스포린 유사 아미노산을 생산하는 미생물 및 이를 이용한 마이코스포린 유사 아미노산의 생산방법
CN108484438A (zh) * 2018-03-06 2018-09-04 佛山科学技术学院 一种从紫菜中提取类菌胞素氨基酸的方法
CN108421031A (zh) * 2018-04-13 2018-08-21 桂林医学院 藻蓝蛋白在制备防治帕金森病药物中的应用
CN108752445B (zh) * 2018-06-20 2021-04-30 广东药科大学 一种螺旋藻蛋白的制备工艺及其神经保护用途
CN111700903B (zh) * 2020-08-07 2022-03-11 华侨大学 一种紫菜多糖的应用及紫菜多糖的制备方法
KR102694496B1 (ko) 2021-08-18 2024-08-13 전남대학교산학협력단 마이코스포린-유사 아미노산을 유효성분으로 포함하는 비만 예방 또는 치료용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5865216A (ja) 1981-09-16 1983-04-18 Dainippon Ink & Chem Inc 抗腫瘍剤
US5455276A (en) * 1993-05-20 1995-10-03 Sabelli; Hector C. Method for treating depression
US6814961B1 (en) * 2001-05-14 2004-11-09 Gitte S. Jensen Method for enhancing stem cell trafficking
KR101489728B1 (ko) * 2005-06-24 2015-02-04 데저트 레이크 테크놀로지스 남조류의 정제된 성분 및 이용 방법

Also Published As

Publication number Publication date
CA2656154C (en) 2017-02-28
CN101478980B (zh) 2013-03-20
CN101478980A (zh) 2009-07-08
AU2007264042B2 (en) 2012-01-12
SI2046354T1 (sl) 2011-11-30
EP2046354A2 (en) 2009-04-15
WO2008000430A2 (en) 2008-01-03
RS52072B (en) 2012-06-30
US9522167B2 (en) 2016-12-20
PL2046354T3 (pl) 2012-01-31
IL196132A0 (en) 2009-09-22
ZA200900747B (en) 2010-05-26
EP2046354B1 (en) 2011-08-10
JP2009541388A (ja) 2009-11-26
AU2007264042A1 (en) 2008-01-03
HRP20110771T1 (hr) 2011-11-30
KR20090035490A (ko) 2009-04-09
MY146594A (en) 2012-08-30
WO2008000430A3 (en) 2008-03-27
JP5259585B2 (ja) 2013-08-07
ATE519491T1 (de) 2011-08-15
DK2046354T3 (da) 2011-10-31
PT2046354E (pt) 2011-11-09
RU2008151175A (ru) 2010-06-27
ES2370533T3 (es) 2011-12-19
RU2441663C2 (ru) 2012-02-10
US20090311286A1 (en) 2009-12-17
CA2656154A1 (en) 2008-01-03

Similar Documents

Publication Publication Date Title
AU2007264042B2 (en) Alphanizomenon Flos Aquae preparation, extracts and purified components thereof for the treatment of neurological, neurodegenerative and mood disorders
Kar et al. Antioxidant and in vitro anti-inflammatory activities of Mimusops elengi leaves
KR20090048399A (ko) 아파니조메논 플로스 아쿠애 추출물 및 이를 포함하는 영양, 미용 및 약제학적 조성물
Que et al. In vitro and vivo antioxidant activities of daylily flowers and the involvement of phenolic compounds
Saati Antioxidant power of rose anthocyanin pigment
Gomathi et al. Analgesic and acetylcholinesterase inhibition potential of polyphenols from Scolopia crenata (Flacourtiaceae): An endemic medicinal plant of India
Hassan et al. Anti-inflammatory activity, total flavonoids and tannin content from the ethanolic extract of Ageratum conyzoides linn. Leaf
WO2013021076A1 (es) Extracto de uva, complemento nutricional que lo comprende y su uso como ingrediente funcional
Essa et al. Protective influence of Pongamia pinnata (Karanja) on blood ammonia and urea levels in ammonium chloride-induced hyperammonemia
Misra et al. Protection of swimming-induced oxidative stress in some vital organs by the treatment of composite extract of Withania somnifera, Ocimum sanctum and Zingiber officinalis in male rat
US20170128503A1 (en) Neuro-modulating preparations for treatment of neurological and mood disorders
US7494674B2 (en) Nutraceutical with tart cherries and method of treatment therewith
Dixit et al. A review on biosynthesis, characterization and antimicrobial effect of silver nanoparticles of Moringa olifera (MO-AgNPs)
Bulbul et al. Anti-nociceptive and anti-inflammatory activities of Crotalaria pallida Aiton (Fam: Fabaceae) leaves
Kuum et al. Anti-inflammatory effects of the stem barks from Albizia ferruginea (Mimosaceae) on chronic inflammation induced in rats
AQUAE et al. THEREOF FOR THE TREATMENT OF NEUROLOGICAL, NEURODEGENERATIVE AND MOOD DISORDERS
EP1663268B1 (en) Oral compositions and route of administration for the delivery of a thylakoid extract
KR20100060949A (ko) 신경세포 보호용 조성물
WO2010129524A2 (en) Plant medicinal compounds
A Sh et al. Efficacy of aqueous extract of saffron (Crocus sativus L.) in modulating radiation-induced brain and eye retina damage in rats
Yan et al. The new products from brown seaweeds: Fucoxanthin and phlorotannins
Al-Naqeb Caralluma flava NE Br extract reduces plasma glucose level and improves plasma antioxidant enzymes in hyperglycemic rats
BENBOTT et al. Indian Journal of Novel Drug Delivery
Rajalakshmi Evaluation of antioxidant property of purified phycobiliproteins and phenolic compounds containing extracts from bangia atropurpurea
KR100446090B1 (ko) 사우로락탐계 알카로이드의 퇴행성 뇌신경계 질환의 예방과 치료제로서의 용도 및 이 화합물을 유효성분으로 함유하는 약학적 제제

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed